{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:43:48Z","timestamp":1767192228747},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.8591","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T04:16:38Z","timestamp":1363320998000},"page":"673-677","source":"Crossref","is-referenced-by-count":4,"title":["Multiple Unrelated Malignancies Following Renal Transplantation: An Evaluation of Four Cases"],"prefix":"10.2169","volume":"52","author":[{"given":"Erhan","family":"Tatar","sequence":"first","affiliation":[{"name":"Division of Nephrology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Sarsik","sequence":"additional","affiliation":[{"name":"Division of Pathology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozkan","family":"Gungor","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Yaman","sequence":"additional","affiliation":[{"name":"Division of Pathology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazan","family":"Ozsan","sequence":"additional","affiliation":[{"name":"Division of Pathology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seckin","family":"Cagirgan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Sezis Demirci","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylan","family":"Ozgur Sezer","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuneyt","family":"Hoscoskun","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Toz","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Ege University School of Medicine, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zeier M, Hartschuh W, Wiesel M, et al. Malignancy after renal transplantation. Am J Kidney Dis 39: 5, 2002.","DOI":"10.1053\/ajkd.2002.29926"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Peto J. Cancer epidemiology in the last century and the next decade. Nature 411: 390-395, 2001.","DOI":"10.1038\/35077256"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 296: 2823-2831, 2006.","DOI":"10.1001\/jama.296.23.2823"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 60: 183-189, 1995.","DOI":"10.1002\/ijc.2910600209"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vasudev B, Hariharan S. Cancer after renal transplantation. Curr Opin Nephrol Hypertens 16: 523-528, 2007.","DOI":"10.1097\/MNH.0b013e3282f06bba"},{"key":"6","unstructured":"6. Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant 22 Suppl 1: i4-i10, 2007."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Danpanich E, Kasiske BL. Risk factors for cancer in renal transplant recipients. Transplantation 68: 1859-1864, 1999.","DOI":"10.1097\/00007890-199912270-00008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bordea C, Wojnarowska F, Millard PR, et al. Skin cancer in renal-transplant recipients occurs more frequently than previously recognized in a temperate climate. Transplantation 77: 574-579, 2004.","DOI":"10.1097\/01.TP.0000108491.62935.DF"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ramsay HM, Fryer AA, Reece S, et al. Clinical risk factors associated with non-melanoma skin cancer in renal transplant recipients. Am J Kidney Dis 36: 167-176, 2000.","DOI":"10.1053\/ajkd.2000.8290"},{"key":"10","unstructured":"10. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 23: 101-113, 2000."},{"key":"11","unstructured":"11. Bouwes-Bavnick JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: A follow-up study. Transplantation 61: 715-721, 1996."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. American Journal of Transplantation 9 (Suppl 3): S1-S155, 2009.","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Barroso-Vicens E, Ramirez G, Rabb H. Multiple primary malignancies in a renal transplant patient. Transplantation 61: 1655-1656, 1996.","DOI":"10.1097\/00007890-199606150-00020"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. G&oacute;mez E, Portal CG, Seco MA, Alvarez-Grande J. Multiple solid malignancies in a renal transplant patient. Nephrol Dial Transplant 14: 803-804, 1999.","DOI":"10.1093\/ndt\/14.3.803"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hilario R, Padre-Mendoza T, Albala MM. Chronic granulocytic leukemia and carcinoma of the cervix in situ following renal transplantation. Am J Med Sci 280: 115-118, 1980.","DOI":"10.1097\/00000441-198009000-00008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Studniberg HM, Rivers JK, Cooke BE, Barnetson RS. The coexistence of lymphangiosarcoma and Kaposi's sarcoma in a renal transplant recipient. Cancer 68: 2330-2335, 1991.","DOI":"10.1002\/1097-0142(19911115)68:10<2330::AID-CNCR2820681037>3.0.CO;2-S"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Childs LC, Harris MJ, Lucas BA, Kenady DE. Primary biliary and pancreatic carcinoma after renal transplantation. South Med J 83: 849-850, 1990.","DOI":"10.1097\/00007611-199007000-00031"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Motoyama O, Takasu J, Kawamura T, et al. A male patient with malignant lymphoma and thyroid papillary carcinoma after pediatric renal transplantation. Clin Exp Nephrol 14: 94-96, 2010.","DOI":"10.1007\/s10157-009-0210-6"},{"key":"19","unstructured":"19. Lo Monte AI, Palumbo VD, Damiano G, et al. Double endocrine neoplasia in a renal transplant recipient: case report and review of the literature. Transplant Proc 43: 1201-1205, 2011."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Swann PF, Waters TR, Moulton DC, et al. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273: 1109-1111, 1996.","DOI":"10.1126\/science.273.5278.1109"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Herman M, Weinstein T, Korzets A, et al. Effect of cyclosporin A on DNA repair and cancer incidence in renal transplant recipients. J Lab Clin Med 137: 14-20, 2001.","DOI":"10.1067\/mlc.2001.111469"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. David KM, Morris JA, Steffen BJ, et al. Mycophenolate mofetil vs azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pretransplant diabetes. Clin Transplant 19: 279-285, 2005.","DOI":"10.1111\/j.1399-0012.2005.00338.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 80: 883-889, 2005.","DOI":"10.1097\/01.TP.0000184006.43152.8D"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/6\/52_52.8591\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:48:22Z","timestamp":1621446502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/6\/52_52.8591\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.8591","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}